Cipla

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various... Wikipedia

• Trading name:  Cipla
• Formerly called:  Chemical Industrial & Pharmaceutical Laboratories Ltd. (1935–1984)
• Type:  Public
• Traded as:  BSE: 500087, NSE: CIPLA, NSE NIFTY 50 constituent
• ISIN:  [ ISIN: [ INE059A01026]]
• Industry:  Pharmaceuticals
• Founded:  1935
• Founder:  Khwaja Abdul Hamied
• Area served:  Worldwide
• Key people:  Y. K. Hamied (Chairperson), Umang Vohra (CEO)
• Products:  Pharmaceutical drugs, generic drugs, antiviral drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health, dietary supplements, protein supplements
• Revenue:  ₹ 27,548 crore (2025)
• Operating income:  ₹ 7,128 crore (2025)
• Total assets:  ₹ 37,387 crore (2025)
• Total equity:  ₹ 31,289 crore (2025)
• Number of employees:  27,764 (March 2024)
• Subsidiaries:  Invagen Pharmaceuticals
• Website:  www.cipla.com
• Data source:  DuckDuckGo